Back
CRISPR Therapeutics AG Quote, Financials, Valuation and Earnings
Sponsored
CRSP
Sponsored
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.
Sell
47
CRSP
CRISPR Therapeutics AG
Last Price:
55.88
Seasonality Move:
21.78%
7 Day Trial
ALL ACCESS PASS
$
7
NOW is the time to get in on this trillion-dollar megatrend
Get it here.CRISPR Therapeutics AG Price Quote
$55.88
-0.01 (1.41%)
(Updated: May 4, 2024 at 6:14 AM ET)
CRISPR Therapeutics AG Key Stats
Sell
47
CRISPR Therapeutics AG (CRSP)
is a Sell
Day range:
$55.57 - $58.45
52-week range:
$37.55 - $91.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.52%
Volume:
1.4M
Avg. volume:
1.3M
1-year change:
13.62%
Market cap:
$4.7B
Revenue:
$370M
EPS:
$-1.93
How Much Does CRISPR Therapeutics AG Make?
Data Unavailable
Is CRISPR Therapeutics AG Growing As A Company?
-
What Is CRISPR Therapeutics AG's Growth Rate Quarterly?
Quarterly YoY revenue growth is 33332.33% -
What Is CRISPR Therapeutics AG's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
CRISPR Therapeutics AG Stock Price Performance
-
Did CRISPR Therapeutics AG Stock Go Up Last Month?
CRISPR Therapeutics AG share price went down by -13.48% last month -
Did CRSP's Share Price Rise Over The Last Year?
CRSP share price rose by 13.62% over the past 1 year
What Is CRISPR Therapeutics AG 52-Week High & Low?
-
What Is CRISPR Therapeutics AG’s 52-Week High Share Price?
CRISPR Therapeutics AG has traded as high as $91.10 over the past 52 weeks -
What Is CRISPR Therapeutics AG’s 52-Week Low Share Price?
CRISPR Therapeutics AG has traded as low as $37.55 over the past 52 weeks
CRISPR Therapeutics AG Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy CRISPR Therapeutics AG?
-
How Much Debt Does CRISPR Therapeutics AG Have?
Total long term debt quarterly is $0 -
How Much Cash Does CRISPR Therapeutics AG Have?
Cash and short term investments quarterly total is $1.7B -
What Is CRISPR Therapeutics AG’s Book Value Per Share?
Book value per share is 23.52
Is CRISPR Therapeutics AG Cash Flow Positive?
-
What Is CRSP Cash Flow From Operations?
Cash flow from operations (TTM) is -$260.4M -
What Is CRISPR Therapeutics AG’s Cash Flow From Financing?
Cash flow from financing (TTM) is $62.7M -
What Is CRISPR Therapeutics AG’s Cash Flow From Investing?
Cash flow from investing (TTM) is $374.6M
CRISPR Therapeutics AG Return On Invested Capital
-
Is Management Doing A Good Job?
CRSP return on invested capital is -8.39% -
What Is CRISPR Therapeutics AG Return On Assets?
ROA measures how assets are converting to revenues and is -6.98% -
What Is CRSP Return On Equity?
ROE is a measure of profitability and is -8.39%
CRISPR Therapeutics AG Earnings Date & Stock Price
-
What Is CRISPR Therapeutics AG's Stock Price Today?
A single share of CRSP can be purchased today for 55.89 -
What Is CRISPR Therapeutics AG’s Stock Symbol?
CRISPR Therapeutics AG trades on the nasdaq under the ticker symbol: CRSP -
When Is CRISPR Therapeutics AG’s Next Earnings Date?
The next quarterly earnings date for CRISPR Therapeutics AG is scheduled on May 8, 2024 -
When Is CRSP's next ex-dividend date?
CRISPR Therapeutics AG's next ex-dividend date is May 5, 2024 -
How To Buy CRISPR Therapeutics AG Stock?
You can buy CRISPR Therapeutics AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
CRISPR Therapeutics AG Competitors
-
Who Are CRISPR Therapeutics AG's Competitors?
Below is a list of companies who compete with CRISPR Therapeutics AG or are related in some way:
CRISPR Therapeutics AG Dividend Yield
Data Unavailable
CRISPR Therapeutics AG Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 2212.87% |
Revenue: | 3333233.33% | 63.47% |
Analyst Recommendations
Buy Recommendations: | 10 |
---|---|
Hold Recommendations: | 11 |
Sell Recommendations: | 2 |
Price Target: | 88.13 |
Upside from Last Price: | 57.68% |